Based on the totality of our findings, we propose the following model (Figure 10): CCL16 (a potential cancer stemness gene) binds to the CCR2 receptor and activates p-AKT/GSK3β signaling, which enhances β-catenin stability and promotes β-catenin nuclear translocation. The gene discussed is AKT1; the disease is cancer.